Hanson McClain Advisors »

Trisalus Life Sciences shares owned by Hanson McClain Advisors

Quarter-by-quarter ownership of Trisalus Life Sciences (TLSI) shares owned by Hanson McClain Advisors from 13F filings

Historical chart of Hanson McClain Advisors investment in Trisalus Life Sciences

Tip: Access up to 7 years of quarterly data

All positions including Trisalus Life Sciences held by Hanson McClain Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Trisalus Life Sciences by Hanson McClain Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $4 1 4.00

More positions owned by Hanson McClain Advisors

Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Spdr Index Shs Fds State Street Spd (SPDW)
Spdr Series Trust State Street Spd (SPYG)
Spdr Series Trust State Street Spd (SPYV)
Ishares Tr Us Treas Bd Etf (GOVT)
Apple Call Call Option (Principal) (AAPL)
Vanguard Index Fds Mid Cap Etf (VO)
Spdr Index Shs Fds State Street Spd (SPEM)
J P Morgan Exchange Traded F Active Bond Etf (JBND)
Ishares Tr Mbs Etf (MBB)
Ishares Tr Usd Inv Grde Etf (USIG)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Gmo Etf Trust Gmo Us Quality E (QLTY)

View all positions for Hanson McClain Advisors

Top funds holding Trisalus Life Sciences

First Light Asset Management
AWM Investment Company
Nantahala Capital Management
BlackRock
Vanguard Capital Management
Gilder, Gagnon, Howe & Co
HPM Partners
Geode Capital Management
Thompson, Siegel, & Walmsley
Kennedy Capital Management
Morgan Stanley
State Street Corporation
Empire Financial Management Company
Perkins Capital Management
Northern Trust

View all funds holding Trisalus Life Sciences